1
|
Monroy GL, Pande P, Nolan RM, Shelton RL, Porter RG, Novak MA, Spillman DR, Chaney EJ, McCormick DT, Boppart SA. Noninvasive in vivo optical coherence tomography tracking of chronic otitis media in pediatric subjects after surgical intervention. J Biomed Opt 2017; 22:1-11. [PMID: 29275547 PMCID: PMC5745859 DOI: 10.1117/1.jbo.22.12.121614] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2017] [Accepted: 12/15/2017] [Indexed: 05/12/2023]
Abstract
In an institutional review board-approved study, 25 pediatric subjects diagnosed with chronic or recurrent otitis media were observed over a period of six months with optical coherence tomography (OCT). Subjects were followed throughout their treatment at the initial patient evaluation and preoperative consultation, surgery (intraoperative imaging), and postoperative follow-up, followed by an additional six months of records-based observation. At each time point, the tympanic membrane (at the light reflex region) and directly adjacent middle-ear cavity were observed in vivo with a handheld OCT probe and portable system. Imaging results were compared with clinical outcomes to correlate the clearance of symptoms in relation to changes in the image-based features of infection. OCT images of most all participants showed the presence of additional infection-related biofilm structures during their initial consultation visit and similarly for subjects imaged intraoperatively before myringotomy. Subjects with successful treatment (no recurrence of infectious symptoms) had no additional structures visible in OCT images during the postoperative visit. OCT image findings suggest surgical intervention consisting of myringotomy and tympanostomy tube placement provides a means to clear the middle ear of infection-related components, including middle-ear fluid and biofilms. Furthermore, OCT was demonstrated as a rapid diagnostic tool to prospectively monitor patients in both outpatient and surgical settings.
Collapse
Affiliation(s)
- Guillermo L. Monroy
- University of Illinois at Urbana-Champaign, Department of Bioengineering, Urbana, Illinois, United States
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
| | - Paritosh Pande
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
| | - Ryan M. Nolan
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
| | - Ryan L. Shelton
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
- University of Illinois at Urbana-Champaign, Department of Electrical and Computer Engineering, Urbana, Illinois, United States
| | - Ryan G. Porter
- Carle Foundation Hospital, Department of Otolaryngology, Urbana, Illinois, United States
- University of Illinois at Urbana-Champaign, Carle–Illinois College of Medicine, Urbana, Illinois, United States
| | - Michael A. Novak
- Carle Foundation Hospital, Department of Otolaryngology, Urbana, Illinois, United States
- University of Illinois at Urbana-Champaign, Carle–Illinois College of Medicine, Urbana, Illinois, United States
| | - Darold R. Spillman
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
| | - Eric J. Chaney
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
| | | | - Stephen A. Boppart
- University of Illinois at Urbana-Champaign, Department of Bioengineering, Urbana, Illinois, United States
- Beckman Institute for Advanced Science and Technology, Urbana, Illinois, United States
- University of Illinois at Urbana-Champaign, Department of Electrical and Computer Engineering, Urbana, Illinois, United States
- University of Illinois at Urbana-Champaign, Carle–Illinois College of Medicine, Urbana, Illinois, United States
- Address all correspondence to: Stephen A. Boppart, E-mail:
| |
Collapse
|
2
|
Erickson-Bhatt SJ, Nolan RM, Shemonski ND, Adie SG, Putney J, Darga D, McCormick DT, Cittadine AJ, Zysk AM, Marjanovic M, Chaney EJ, Monroy GL, South FA, Cradock KA, Liu ZG, Sundaram M, Ray PS, Boppart SA. Real-time Imaging of the Resection Bed Using a Handheld Probe to Reduce Incidence of Microscopic Positive Margins in Cancer Surgery. Cancer Res 2016; 75:3706-12. [PMID: 26374464 DOI: 10.1158/0008-5472.can-15-0464] [Citation(s) in RCA: 97] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Wide local excision (WLE) is a common surgical intervention for solid tumors such as those in melanoma, breast, pancreatic, and gastrointestinal cancer. However, adequate margin assessment during WLE remains a significant challenge, resulting in surgical reinterventions to achieve adequate local control. Currently, no label-free imaging method is available for surgeons to examine the resection bed in vivo for microscopic residual cancer. Optical coherence tomography (OCT) enables real-time high-resolution imaging of tissue microstructure. Previous studies have demonstrated that OCT analysis of excised tissue specimens can distinguish between normal and cancerous tissues by identifying the heterogeneous and disorganized microscopic tissue structures indicative of malignancy. In this translational study involving 35 patients, a handheld surgical OCT imaging probe was developed for in vivo use to assess margins both in the resection bed and on excised specimens for the microscopic presence of cancer. The image results from OCT showed structural differences between normal and cancerous tissue within the resection bed following WLE of the human breast. The ex vivo images were compared with standard postoperative histopathology to yield sensitivity of 91.7% [95% confidence interval (CI), 62.5%-100%] and specificity of 92.1% (95% CI, 78.4%-98%). This study demonstrates in vivo OCT imaging of the resection bed during WLE with the potential for real-time microscopic image-guided surgery.
Collapse
Affiliation(s)
- Sarah J Erickson-Bhatt
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Ryan M Nolan
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Nathan D Shemonski
- Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Steven G Adie
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | | | | | | | | | - Adam M Zysk
- Diagnostic Photonics, Inc., Chicago, Illinois
| | - Marina Marjanovic
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Eric J Chaney
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Guillermo L Monroy
- Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Fredrick A South
- Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | | | | | - Magesh Sundaram
- Carle Foundation Hospital, Urbana, Illinois. Department of Surgery, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Partha S Ray
- Carle Foundation Hospital, Urbana, Illinois. Department of Surgery, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois
| | - Stephen A Boppart
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois. Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois. Diagnostic Photonics, Inc., Chicago, Illinois. Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois. Carle Foundation Hospital, Urbana, Illinois.
| |
Collapse
|
3
|
Chen X, Xu X, McCormick DT, Wong K, Wong ST. Multimodal nonlinear endo-microscopy probe design for high resolution, label-free intraoperative imaging. Biomed Opt Express 2015; 6. [PMID: 26203361 PMCID: PMC4505689 DOI: 10.1364/boe.6.002283] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
We present a portable, multimodal, nonlinear endo-microscopy probe designed for intraoperative oncological imaging. Application of a four-wave mixing noise suppression scheme using dual wavelength wave plates (DWW) and a polarization-maintaining fiber improves tissue signal collection efficiency, allowing for miniaturization. The probe, with a small 14 mm transversal diameter, includes a customized miniaturized two-axis MEMS (micro-electromechanical system) raster scanning mirror and micro-optics with an illumination laser delivered by a polarization-maintaining fiber. The probe can potentially be integrated into the arms of a surgical robot, such as da Vinci robotic surgery system, due to its minimal cross sectional area. It has the ability to incorporate multiple imaging modalities including CARS (coherent anti-Stokes Raman scattering), SHG (second harmonic generation), and TPEF (two-photon excited fluorescence) in order to allow the surgeon to locate tumor cells within the context of normal stromal tissue. The resolution of the endo-microscope is experimentally determined to be 0.78 µm, a high level of accuracy for such a compact probe setup. The expected resolution of the as-built multimodal, nonlinear, endo-microscopy probe is 1 µm based on the calculation tolerance allocation using Monte-Carlo simulation. The reported probe is intended for use in laparoscopic or radical prostatectomy, including detection of tumor margins and avoidance of nerve impairment during surgery.
Collapse
Affiliation(s)
- Xu Chen
- Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medical College, Houston, Texas 77030, USA
| | - Xiaoyun Xu
- Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medical College, Houston, Texas 77030, USA
| | | | - Kelvin Wong
- Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medical College, Houston, Texas 77030, USA
- Department of Radiology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, Texas 77030, USA
| | - Stephen T.C. Wong
- Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medical College, Houston, Texas 77030, USA
- Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Cornell Medical College, Houston, Texas 77030, USA
- Department of Radiology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, Texas 77030, USA
| |
Collapse
|
4
|
Monroy GL, Shelton RL, Nolan RM, Nguyen CT, Novak MA, Hill MC, McCormick DT, Boppart SA. Noninvasive depth-resolved optical measurements of the tympanic membrane and middle ear for differentiating otitis media. Laryngoscope 2015; 125:E276-82. [PMID: 25599652 DOI: 10.1002/lary.25141] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 11/17/2014] [Accepted: 12/15/2014] [Indexed: 12/22/2022]
Abstract
OBJECTIVE/HYPOTHESIS In this study, optical coherence tomography (OCT) is used to noninvasively and quantitatively determine tympanic membrane (TM) thickness and the presence and thickness of any middle-ear biofilm located behind the TM. These new metrics offer the potential to differentiate normal, acute, and chronic otitis media (OM) infections in pediatric subjects. STUDY DESIGN Case series with comparison group. METHODS The TM thickness of 34 pediatric subjects was acquired using a custom-built, handheld OCT system following a traditional otoscopic ear exam. RESULTS Overall thickness (TM and any associated biofilm) was shown to be statistically different for normal, acute, and chronic infection groups (normal-acute and normal-chronic: P value < 0.001; acute-chronic: P value = 0.0016). Almost all observed scans from the chronic group had an accompanying biofilm structure. When the thickness of the TM and biofilm were considered separately in chronic OM, the chronic TM thickness correlated with the normal group (P value = 0.68) yet was still distinct from the acute OM group (P value < 0.001), indicating that the TM in chronic OM returns to relatively normal thickness levels. CONCLUSION Identifying these physical changes in vivo provides new metrics for noninvasively and quantitatively differentiating normal, acute, and chronic OM. This new diagnostic information has the potential to assist physicians to more effectively and efficiently screen, manage, and refer patients based on quantitative data. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- Guillermo L Monroy
- Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A
| | - Ryan L Shelton
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A
| | - Ryan M Nolan
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A
| | - Cac T Nguyen
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A
| | - Michael A Novak
- Department of Surgery, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Department of Otolaryngology, Urbana, Illinois, U.S.A
| | - Malcolm C Hill
- Department of Pediatrics, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Department of Pediatrics, Urbana, Illinois, U.S.A
| | - Daniel T McCormick
- Carle Foundation Hospital, Urbana, Illinois, U.S.A.,Advanced MEMS, San Francisco, California, U.S.A
| | - Stephen A Boppart
- Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A.,Department of Internal Medicine, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, U.S.A
| |
Collapse
|
5
|
Shelton RL, Jung W, Sayegh SI, McCormick DT, Kim J, Boppart SA. Optical coherence tomography for advanced screening in the primary care office. J Biophotonics 2014; 7:525-33. [PMID: 23606343 PMCID: PMC3922891 DOI: 10.1002/jbio.201200243] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/24/2012] [Revised: 03/15/2013] [Accepted: 03/16/2013] [Indexed: 05/26/2023]
Abstract
Optical coherence tomography (OCT) has long been used as a diagnostic tool in the field of ophthalmology. The ability to observe microstructural changes in the tissues of the eye has proved very effective in diagnosing ocular disease. However, this technology has yet to be introduced into the primary care office, where indications of disease are first encountered. We have developed a portable, handheld imaging probe for use in the primary care setting and evaluated its tissue site accessibility, ability to observe diseased tissue, and screening capabilities in in vivo human patients, particularly for pathologies related to the eye, ear and skin. Various stages of diabetic retinopathy were investigated using the handheld probe and early-stage diabetic retinopathy was flagged as abnormal from the OCT images. At such early stages of disease, it is difficult to observe abnormalities with the limited tools that are currently available to primary care physicians. These results indicate that OCT shows promise to transform from being a diagnostic technology in the medical and surgical specialities to a screening technology in the primary care office and at the front-line of healthcare.
Collapse
Affiliation(s)
- Ryan L. Shelton
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL USA
| | - Woonggyu Jung
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL USA
- School of Nano-Bioscience and Chemical Engineering, Ulsan National Institute of Science and Technology, Korea
| | | | | | - Jeehyun Kim
- Department of Electrical and Computer Engineering, Kyungpook National University, Korea
| | - Stephen A. Boppart
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL USA
- Departments of Electrical and Computer Engineering, Bioengineering, and Medicine, University of Illinois at Urbana-Champaign, Urbana, IL USA
| |
Collapse
|
6
|
Sayegh SI, Nolan RM, Jung W, Kim J, McCormick DT, Chaney EJ, Stewart CN, Boppart SA. Comparison of a MEMS-Based Handheld OCT Scanner With a Commercial Desktop OCT System for Retinal Evaluation. Transl Vis Sci Technol 2014. [DOI: 10.1167/tvst.3.4.3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
7
|
Sayegh SI, Nolan RM, Jung W, Kim J, McCormick DT, Chaney EJ, Stewart CN, Boppart SA. Comparison of a MEMS-Based Handheld OCT Scanner With a Commercial Desktop OCT System for Retinal Evaluation. Transl Vis Sci Technol 2014; 3:10. [PMID: 25068092 DOI: 10.1167/tvst.3.3.10] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2013] [Accepted: 04/27/2014] [Indexed: 01/15/2023] Open
Abstract
PURPOSE The goal of this study was to evaluate the ability of our handheld optical coherence tomography (OCT) scanner to image the posterior and anterior structures of the human eye, and especially the individual layers of the retina, and to compare its diagnostic performance with that of a fixed desktop commercial ophthalmic OCT system. METHODS We compared the clinical imaging results of our handheld OCT with a leading commercial desktop ophthalmic system (RTVue) used in specialist offices. Six patients exhibiting diabetes-related retinal pathology had both eyes imaged with each OCT system. RESULTS In both sets of images, the structural irregularities of the retinal layers could be identified such as retinal edema and vitreomacular traction. CONCLUSIONS Our handheld OCT system can be used to identify relevant anatomical structures and pathologies in the eye, potentially enabling earlier screening, disease detection, and treatment. Images can be acquired quickly, with sufficient resolution and negligible motion artifacts that would normally limit its diagnostic use. TRANSLATIONAL RELEVANCE Following screening and early disease detection in primary care via our optimized handheld OCT system, patients can be referred to a specialist for treatment, preventing further disease progression. While many primary care physicians are adept at using the ophthalmoscope, they can definitely take advantage of more advanced technologies.
Collapse
Affiliation(s)
| | - Ryan M Nolan
- Beckman Institute for Advanced Science and Technology, Urbana, IL, USA
| | - Woonggyu Jung
- School of Nano-Bioscience and Chemical Engineering, Ulsan National Institute of Science and Technology, Korea
| | - Jeehyun Kim
- Department of Electrical and Computer Engineering, Kyungpook National University, Korea
| | | | - Eric J Chaney
- Beckman Institute for Advanced Science and Technology, Urbana, IL, USA
| | | | - Stephen A Boppart
- Beckman Institute for Advanced Science and Technology, Urbana, IL, USA ; Departments of Electrical and Computer Engineering, Bioengineering, and Internal Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA
| |
Collapse
|
8
|
Boppart SA, Nolan RM, Erickson-Bhatt SJ, Shemonski ND, Adie SG, Putney J, Darga D, McCormick DT, Cittadine A, Marjanovic M, Zysk AM, Chaney EJ, Monroy GL, South FA, Carney PS, Cradock KA, Liu ZG, Ray PS. Abstract P2-03-11: In situ imaging of the tumor cavity during breast lumpectomy using optical coherence tomography. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p2-03-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Re-operation rates for breast lumpectomy procedures are exceedingly high, often over 30%, depending on the institution and surgical technique. Because current standard-of-care relies on post-operative histopathology to provide a microscopic view and assessment of surgical margins, there has been great interest in developing new imaging solutions to visualize tissues intraoperatively with high-resolution, and provide real-time feedback on the margin status. While it is possible to use a variety of microscopic imaging methods in the operating suite, including frozen-section histology, touch-prep cytology, confocal or scattering-based microscopy, all these techniques are limited to visualizing margins on ex vivo resected specimens, and do not provide a means for visualizing the in situ tumor cavity for evidence of positive margins or residual disease.
Optical coherence tomography (OCT) is a high-resolution, real-time, optical biomedical imaging technology that is the optical analogue to ultrasound imaging, except images are based on backscattered near-infrared light. OCT is capable of performing optical biopsies of in situ tissue at resolutions that approach those in histopathology. With the use of an advanced computed imaging technique called ISAM (Interferometric Synthetic Aperture Microscopy), even higher imaging resolution over larger depths is possible, commensurate with the depths (1-2 mm) visualized by pathologists to determine negative, close, or positive margins. Past studies by our group and others have demonstrated the feasibility of intraoperative OCT for assessing tumor margin and lymph node status during breast cancer surgery, but to date, all studies have been performed on resected lumpectomy tissue.
In this study, we report the development of a novel handheld surgical imaging probe that enables 2-D and 3-D OCT/ISAM imaging of the in situ tumor cavity, in addition to the margins of excised specimens. To date, this handheld OCT/ISAM probe has been used in 10 breast cancer surgeries where both in situ and ex vivo imaging was performed. Four of these cases involved in situ imaging of the cavity margin after a suspicious area was visually and tactically identified, and was subsequently resected, followed by ex vivo imaging and validating post-operative histopathology. Representative cases included fibroadipose tissue, fibroadenomas, and high-grade ductal carcinoma in situ.
Distinct microstructural features identified on OCT/ISAM and confirmed with histopathology demonstrate that this technique can visualize the in situ tumor cavity, as well as the surgical margins on resected specimens, with micron-scale resolution. OCT/ISAM has the potential to determine margin status in real-time during the surgical procedure, when further surgical resection to establish clear margins and reduce re-operation rates is possible.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P2-03-11.
Collapse
Affiliation(s)
- SA Boppart
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - RM Nolan
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - SJ Erickson-Bhatt
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - ND Shemonski
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - SG Adie
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - J Putney
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - D Darga
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - DT McCormick
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - A Cittadine
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - M Marjanovic
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - AM Zysk
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - EJ Chaney
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - GL Monroy
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - FA South
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - PS Carney
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - KA Cradock
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - ZG Liu
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| | - PS Ray
- University of Illinois Urbana-Champaign, Urbana, IL; Diagnostic Photonics Inc, Champaign, IL; AdvancedMEMS, San Francisco, CA; Carle Foundation Hospital, Urbana, IL; University of Illinois College of Medicine and Carle Cancer Center, Urbana, IL
| |
Collapse
|
9
|
Jacobs LK, Carney PS, Cittadine AJ, McCormick DT, Somera AL, Darga DA, Putney JL, Adie SG, Ray P, Cradock KA, Tafra L, Gabrielson EW, Boppart SA. Abstract OT2-1-04: Intraoperative assessment of tumor margins with a new optical imaging technology: A multi-center, randomized, blinded clinical trial. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-ot2-1-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Partial mastectomy is the most commonly performed procedure for invasive breast cancer and is associated with a reexcision rate commonly ranging from 20% to 40% in the literature. This high rate of reexcision is associated with significant additional cost (estimated over $4,000 per reexcision) and lower quality outcomes.
Optical coherence tomography (OCT) is a high-resolution imaging technology that images tissue structure with micron-scale resolution – on the same scale as histopathology. It is similar to ultrasound except it uses near infra-red light waves instead of sound waves to create detailed images several millimeters deep into tissue. Although widely used in ophthalmology with growing use in cardiovascular imaging, high-resolution OCT imaging has a narrow depth of focus and requires instrumentation that is not well suited for intraoperative use. Drawing from OCT technology, interferometric synthetic aperture microscopy (ISAM) is a computational imaging technique that creates high-resolution, always in-focus images in software with basic optical instrumentation. A high-resolution ISAM probe and imaging system has been developed for intraoperative imaging of tissue structure and has the potential to broadly impact intraoperative assessment of tumor margins. Intraoperative ISAM imaging of the excised breast cancer specimen margins and in vivo imaging within the surgical cavity may reduce the high rate of reexcision associated with partial mastectomy.
Trial Design: The trial design is a prospective, multi-center, randomized, double arm study comparing the reexcision rate of standard of care partial mastectomy versus the reexcision rate of standard of care partial mastectomy plus intraoperative ISAM imaging.
Inclusion Criteria: Women histologically diagnosed with invasive carcinoma of the breast (invasive ductal or lobular)Undergoing partial mastectomy (lumpectomy) procedureAge 18 years or more
Exclusion Criteria Multicentric diseaseBilateral diseaseNeoadjuvant systemic therapyAll T4 tumorsPrevious radiation in the operated breastPrior surgical procedure in the same quadrantImplants in the operated breastPregnancyLactationParticipating in any other investigational study which can influence collection of valid data
Primary Endpoints Measure of surgical reexcision rateRate of tumor at final surgical marginsSecondary EndpointsVolume of tissue excisedClinical and economic measures of addressing asymmetry
Statistical Methods: The trial is designed to show superiority of the ISAM imaging arm to the standard of care. Statistical design is two group, continuity corrected chi-squared test of equal proportions with 90% power and alpha=0.05. The trial design assumes a baseline reoperation rate in the standard of care arm of 24% with at least a 50% reduction in the ISAM imaging arm.
Present Accrual and Target Accrual
Not yet recruiting. Target accrual is 230 patients in the partial mastectomy + imaging arm and 230 patients in the standard of care partial mastectomy arm.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr OT2-1-04.
Collapse
Affiliation(s)
- LK Jacobs
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - PS Carney
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - AJ Cittadine
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - DT McCormick
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - AL Somera
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - DA Darga
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - JL Putney
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - SG Adie
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - P Ray
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - KA Cradock
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - L Tafra
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - EW Gabrielson
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| | - SA Boppart
- The Johns Hopkins University School of Medicine, Baltimore, MD; University of Illinois, Urbana, IL; Diagnostic Photonics, Inc, Chicago, IL; Carle Foundation Hospital, Urbana, IL; AdvancedMEMS, San Francisco, CA; Anne Arundel Medical Center, Annapolis, MD
| |
Collapse
|
10
|
Jung W, McCormick DT, Ahn YC, Sepehr A, Brenner M, Wong B, Tien NC, Chen Z. In vivo three-dimensional spectral domain endoscopic optical coherence tomography using a microelectromechanical system mirror. Opt Lett 2007; 32:3239-41. [PMID: 18026266 DOI: 10.1364/ol.32.003239] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/19/2023]
Abstract
A biopsy is a well-known medical test used to evaluate tissue abnormality. Biopsy specimens are invasively taken from part of a lesion and visualized by microscope after chemical treatment. However, diagnosis by means of biopsy is not only variable due to depth and location of specimen but may also damage the specimen. In addition, only a limited number of specimens can be obtained, thus, the entire tissue morphology cannot be observed. We introduce a three-dimensional (3-D) endoscopic optical biopsy via optical coherence tomography employing a dual-axis microelectromechanical system scanning mirror. Since this technique provides high-resolution, noninvasive, direct, and multiple visualization of tissue, it could function as a clinical biopsy with advanced performance. The device was integrated with a conventional endoscope and utilized to generate in vivo 3-D clinical images in humans and animals.
Collapse
Affiliation(s)
- Woonggyu Jung
- Beckman Laser Institute & Department of Biomedical Engineering, University of California, Irvine, USA
| | | | | | | | | | | | | | | |
Collapse
|